Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$216M |
| 2 |
Apple
AAPL
|
+$215M |
| 3 |
KeyCorp
KEY
|
+$212M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$210M |
| 5 |
Synchrony
SYF
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.82B |
| 2 |
Comcast
CMCSA
|
+$427M |
| 3 |
Amazon
AMZN
|
+$418M |
| 4 |
SLB Ltd
SLB
|
+$312M |
| 5 |
Ameren
AEE
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.03% |
| 2 | Energy | 10.22% |
| 3 | Consumer Discretionary | 9.15% |
| 4 | Financials | 9.09% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
New Jersey Resources
NJR
$5.84B
| $11.6M | 0.02% |
352,104
+202,111
| +135% | +$6.19M |
|
852
Globe Life
GL
$14.2B
| $11.6M | 0.02% |
202,585
-93,477
| -32% | -$5.47M |
|
|
HT
853
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $11.6M | 0.02% |
530,789
-48,005
| -8% | -$1.14M |
|
|
PRAH
854
DELISTED
PRA Health Sciences, Inc.
PRAH
| $11.5M | 0.02% |
254,300
+57,697
| +29% | +$2.42M |
|
855
Boise Cascade
BCC
$2.69B
| $11.5M | 0.02% |
449,904
+221,956
| +97% | +$6.34M |
|
|
TWTR
856
DELISTED
Twitter, Inc.
TWTR
| $11.5M | 0.02% |
+496,114
| New | +$13.2M |
|
|
SUNE
857
DELISTED
SUNEDISON, INC COM
SUNE
| $11.4M | 0.02% |
2,246,418
+863,933
| +62% | +$5.3M |
|
858
HEICO Corp
HEI
$49.8B
| $11.4M | 0.02% |
513,442
-396,761
| -44% | -$8.26M |
|
|
INFI
859
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $11.4M | 0.02% |
1,456,285
+1,274,197
| +700% | +$11M |
|
860
Lexicon Pharmaceuticals
LXRX
$1.03B
| $11.3M | 0.02% |
850,407
+531,026
| +166% | +$6.53M |
|
861
Willis Towers Watson
WTW
$31.7B
| $11.3M | 0.02% |
87,936
+41,292
| +89% | +$4.89M |
|
862
CALL
iShares Russell 2000 ETF
IWM
$79.8B
| $11.3M | 0.02% |
100,000
+50,000
| +100% | +$5.77M |
|
|
863
PUT
iShares Russell 2000 ETF
IWM
$79.8B
| $11.3M | 0.02% |
+100,000
| New | +$11.5M |
|
|
XL
864
DELISTED
XL Group Ltd.
XL
| $11.3M | 0.02% |
287,423
-764,687
| -73% | -$29M |
|
|
KTWO
865
DELISTED
K2M Group Holdings, Inc
KTWO
| $11.3M | 0.02% |
570,300
+328,865
| +136% | +$6.39M |
|
866
Essent Group
ESNT
$6.08B
| $11.3M | 0.02% |
514,100
-471,082
| -48% | -$11.4M |
|
867
Unum
UNM
$13.6B
| $11.2M | 0.02% |
337,005
-920,217
| -73% | -$31.7M |
|
|
MACK
868
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $11.2M | 0.02% |
+180,138
| New | +$12.7M |
|
|
SGNT
869
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $11.2M | 0.02% |
703,536
+108,045
| +18% | +$1.7M |
|
|
ESV
870
CALL
DELISTED
Ensco Rowan plc
ESV
| $11.2M | 0.02% |
181,825
| – | – |
|
|
LBMH
871
DELISTED
LIBERATOR MED HLDGS INC (NY)
LBMH
| $11.2M | 0.02% |
3,338,509
-1,589,191
| -32% | -$4.62M |
|
872
Euronet Worldwide
EEFT
$2.72B
| $11.1M | 0.02% |
+153,810
| New | +$11.8M |
|
873
CALL
Air Products & Chemicals
APD
$65.7B
| $11.1M | 0.02% |
+92,426
| New | +$11.6M |
|
|
RPTP
874
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $11.1M | 0.02% |
2,129,374
+1,429,350
| +204% | +$8.29M |
|
|
FNSR
875
DELISTED
Finisar Corp
FNSR
| $11.1M | 0.02% |
761,147
+303,282
| +66% | +$3.75M |
|
Similar funds
Millennium Management's Q4 2015 Portfolio in Review
As of Q4 2015, Millennium Management held 4,144 positions worth $47.6B, down 7.9% from $51.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Millennium Management withdrew a net $5.89B in Q4 2015, closing 779 positions and reducing 1,349 holdings. Its most notable exit was Illumina, an estimated $86.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Energy and Consumer Discretionary.
Against the trend, Millennium Management opened a new position in Alphabet (Google) Class A worth $221M.
- Millennium Management's largest Q4 2015 buy was Alphabet (Google) Class A: 5,673,120 shares worth $221M.
- Millennium Management added most to Merck in Q4 2015, an estimated $216M increase.
- Millennium Management's biggest Q4 2015 reduction was DuPont de Nemours, cutting an estimated $1.82B.
- Millennium Management fully exited Illumina in Q4 2015, selling an estimated $86.9M.
- Millennium Management's ten largest holdings make up 10% of its $47.6B portfolio in Q4 2015.
- Millennium Management opened 733 new positions and closed 779 in Q4 2015.
- Millennium Management's portfolio value fell 7.9% quarter-over-quarter to $47.6B.
Based on Millennium Management's 13F filing for Q4 2015, filed 16 Feb 2016.